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TO THE EDITOR
IL6-Gene Variation in Parkinson’s Disease
I have read with interest the recent report on the putative
impact of chemokine polymorphisms in Parkinson's Disease1.
Based on a meta-analysis of case-control investigations for IL-6
and several other candidate genes, the authors concluded
protective effects of an IL-6 promoter variant, rs1800795 or IL-
6 G[-174]C. However, key issues appear to have been
overlooked. Firstly, the study by Infante et al2 used a TaqMan
genotyping procedure with unknown primers. It is therefore
impossible to tell in retrospect whether the transcribed or the
antiparallel DNA strand served for allele calling and whether the
risk allele was "G", or "C". As rs1800795 stands for a canonical
substitution that can be read as "G" or as "C" depending on the
template, strand information is essential to define genetic
exposure. A second study3 used sequence-specific oligo probes
that do not differentiate between "G" and "C" but rather call only
the "C" allele on the transcribed strand. A third study4 genotyped
the non-transcribed strand as can be verified by consulting the
original pyrosequencing protocol. Chu et al failed to correct for
the alternate strand and have mistaken "G" for "C". In other
words, two of the three studies in question are non-informative
and the third gives results that were misinterpreted. Finally, the
authors have muddled IL-6 studies in Table 2 and have omitted
additional studies5.
The confusion of risk and protective alleles emphasizes
further the need for strand-sensitive meta-analyses of G:C and
A:T transversions. It is unfortunate that this procedure is not
routinely implemented in PDGene (URL: http://www.pdgene.
org), a database that was consulted by the authors and that also
offers meta-analyses of case-control investigations. Having
reviewed all PDGene entries for rs1800795, I note that as of
September 2012, data from multiple studies2-4 have been
misassigned to rs13447446, a G:T substitution 63bp downstream
from rs1800795. Other studies that did not investigate rs1800795
are included in PDGene's meta-analysis of this variant. While
Chu et al must be given credit for identifying these errors, the
information available is insufficient to support a protective role
of rs1800795 in Parkinson's disease.
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TO THE EDITOR
A Case of Collet–Sicard Syndrome Caused by Necrotizing
Otitis Externa
Collet–Sicard syndrome (CSS), palsy of cranial nerves nine,
ten, eleven, and twelve, can be caused by a diverse set of
disorders. Collet–Sicard syndrome is distinguished from Villaret
syndrome by the lack of sympathetic nerve fibre involvement.
The most common cause of CSS is otologic tumour1. Other
causes include non-otologic neoplasia (primary or secondary):
parotid tumours, skull base tumours, prostate metastases, kidney
metastases, breast metastases, and melanoma metastases.
Multiple myeloma and schwannomas of the hypoglossal nerve,
and Hodgkin’s disease have been reported as causes. Vascular
lesions including carotid aneurysms and jugular vein phlebitis
can cause CSS. Other rare causes of CSS have been reported1.
Herewith, we report a patient with Collet–Sicard syndrome
resulting from malignant otitis externa (OE) and subsequent
abscess formation. To the best of our knowledge, this is only the
second reported case of infectious CSS.
CASE REPORT
A 67-year-old man presented with a three week history of
progressive dysphagia to solids and liquids accompanied by
episodic regurgitation and emesis of partially digested food. His
past history was significant for type 2 diabetes mellitus,
hypertension, erectile dysfunction, obesity, osteoarthritis, and
hypothyroidism. He had been diagnosed with left sensorineural
hearing loss and left OE five months prior. Ear culture was
positive for Pseudomonas aeruginosa. Despite an aggressive
antibiotic regimen and frequent debridement and microcleaning,
the OE had persisted.
A swallowing assessment prior to neurologic consultation
suggested severely impaired oral and pharyngeal phases of
swallowing with a high risk of aspiration on all textures. This
necessitated a G-tube placement. The patient was admitted to
hospital. Examination by a neurologist showed a deviated tongue
to the left, failure of the left soft palate to rise, severe left
sternocleidomastoid (SCM) and upper trapezius weakness and
atrophy, and mild dysarthria. The initial differential diagnosis
included bulbar-onset amyotrophic lateral sclerosis (ALS).
Subsequent examination 3.5 months later revealed persistent
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